ItAlian ReGistry Of pNeumoniA in immUnocompromised paTients (ARGONAUT)
ConditionCommunity Acquired Pneumonia (CAP)
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorSocieta Italiana di Pneumologia
About this trial
This multicentric, prospective study aims at:
evaluating the prevalence, etiology, characteristics, and 1one-year outcomes of immunocompromised patients hospitalized for Community-Acquired Pneumonia (CAP); conducting biochemical, microbiological and genetic analysis on collected samples.
Eligibility criteria
Qualifiers
AIDS,
Aplastic anemia;
Asplenia;
Hematologic malignancy (e.g., lymphoma/acute or chronic myeloid leukemia/multiple myeloma);
Disqualifiers
None
Trial design
Treatments tested in this trial
- Not listed
Trial groups
No trial groups listed
Sponsors and collaborators
Source ClinicalTrials.gov